Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
As of close of business last night, KORU Medical Systems Inc’s stock clocked out at $5.81, up 2.11% from its previous closing price of $5.69. In other words, the price has increased by $2.11 from its previous closing price. On the day, 0.14 million shares were traded. KRMD stock price reached its highest trading level at $5.93 during the session, while it also had its lowest trading level at $5.71.
Ratios:
To gain a deeper understanding of KRMD’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.92 and its Current Ratio is at 2.48. In the meantime, Its Debt-to-Equity ratio is 0.22 whereas as Long-Term Debt/Eq ratio is at 0.17.
On September 07, 2023, Lake Street started tracking the stock assigning a Buy rating and target price of $4.Lake Street initiated its Buy rating on September 07, 2023, with a $4 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Apr 21 ’25 when Tharby Linda M bought 23,587 shares for $2.20 per share.
Pazdan Christopher bought 14,490 shares of KRMD for $41,157 on Mar 19 ’25. On Mar 19 ’25, another insider, Tharby Linda M, who serves as the Officer of the company, bought 29,813 shares for $2.83 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, KRMD now has a Market Capitalization of 269134624 and an Enterprise Value of 264344000. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.89 while its Price-to-Book (P/B) ratio in mrq is 16.34. Its current Enterprise Value per Revenue stands at 6.766 whereas that against EBITDA is -80.404.
Stock Price History:
The Beta on a monthly basis for KRMD is 0.50, which has changed by 0.46460748 over the last 52 weeks, in comparison to a change of 0.17511821 over the same period for the S&P500. Over the past 52 weeks, KRMD has reached a high of $6.61, while it has fallen to a 52-week low of $1.86. The 50-Day Moving Average of the stock is 16.24%, while the 200-Day Moving Average is calculated to be 53.92%.
Shares Statistics:
It appears that KRMD traded 148.02K shares on average per day over the past three months and 217180 shares per day over the past ten days. A total of 46.29M shares are outstanding, with a floating share count of 43.76M. Insiders hold about 5.53% of the company’s shares, while institutions hold 56.02% stake in the company. Shares short for KRMD as of 1765756800 were 937154 with a Short Ratio of 6.33, compared to 1763078400 on 806586. Therefore, it implies a Short% of Shares Outstanding of 937154 and a Short% of Float of 3.0.
Earnings Estimates
A comprehensive evaluation of KORU Medical Systems Inc (KRMD) is underway, with the input of 4.0 analysts contributing to its current rating.The consensus estimate for the next quarter is -$0.01, with high estimates of $0.0 and low estimates of -$0.02. Analysts are recommending an EPS of between -$0.01 and -$0.07 for the fiscal current year, implying an average EPS of -$0.04. EPS for the following year is $0.01, with 4.0 analysts recommending between $0.06 and -$0.03.
Revenue Estimates
In . The current quarter, 5 analysts expect revenue to total $10.46M. It ranges from a high estimate of $10.6M to a low estimate of $10.3M. As of . The current estimate, KORU Medical Systems Inc’s year-ago sales were $8.84MFor the next quarter, 5 analysts are estimating revenue of $11.18M. There is a high estimate of $11.5M for the next quarter, whereas the lowest estimate is $10.7M.
A total of 5 analysts have provided revenue estimates for KRMD’s current fiscal year. The highest revenue estimate was $40.83M, while the lowest revenue estimate was $40.5M, resulting in an average revenue estimate of $40.69M. In the same quarter a year ago, actual revenue was $33.65MBased on 5 analysts’ estimates, the company’s revenue will be $48.28M in the next fiscal year. The high estimate is $49.5M and the low estimate is $47.1M.
